E Jennifer Edelman

Biographic Data

ID	6766281
NAME	E Jennifer Edelman
GIVEN NAMES	E Jennifer
FAMILY NAME	Edelman
SIGNATURE	EDELMAN E J
AFFILIATIONS	Yale University
ORCID	0000-0002-9375-0489
VERIFIED	Yes
TOTAL WORKS	45
TOTAL CITATIONS	1
AUTHOR COUNT	45
EDITOR COUNT	0
FIRST PUBLICATION YEAR	2010
LATEST PUBLICATION YEAR	2026
H-INDEX	1

Psychosocial correlates of awareness of HIV pre-exposure prophylaxis (PrEP) among persons who inject drugs in Northeast Georgia
Mohammad Rifat Haider, Samantha Clinton et al.ARTICLEAIDS Care2026
Despite Georgia having one of the highest rates of new HIV diagnoses in the United States, uptake of HIV pre-exposure prophylaxis (PrEP) remains critically low. We assessed the psychosocial correlates associated with PrEP awareness among persons who inject drugs (PWID) living in Northeast Georgia. Data were collected from 173 adult (≥18 years) HIV-negative PWID. PrEP awareness was elicited by the question, "Have you ever heard of PrEP?" (Yes/No).…
The Feasibility and Acceptability of a Clinical Pharmacist-delivered Intervention to Reduce Bothersome Health Symptoms from Polypharmacy and Alcohol Use and Communicate Risk among People with HIV
Open AccessJulie A Womack, Micaela M Leblanc et al.ARTICLEAIDS and Behavior2025
Perspectives on Clinical Pharmacist-Delivered Contingency Management to Promote Smoking Abstinence Among Individuals with HIV
Open AccessPoyani Bavishi, Dini Harsono et al.ARTICLEAIDS and Behavior2025
“Recovery is about change, so you have to change everything”
Open AccessElizabeth Jadovich, Adam Viera et al.ARTICLESSM - Qualitative Research in…2024
is a framework in addiction research aiming to understand substance use disorder recovery holistically by considering individuals' access to resources across the four domains of human, physical, social, and community capital. Each domain is opposed by negative capital. The underrepresentation of women's experiences in substance use research and the limited understanding of substance use treatment's effect on recovery capital limits our understand…
Priorities for HIV and chronic pain research
Jessica Robinson‐Papp, Jessica Robinson-Papp et al.ARTICLEAIDS Care2024
The Global Task Force on Chronic Pain in HIV published seven research priorities in the field of HIV-associated chronic pain in 2019: (1) causes; (2) management; (3) treatment individualization and integration with addiction treatment; (4) mental and social health factors; (5) prevalence; (6) treatment cost effectiveness; and (7) prevention. The current study used a web-based survey to determine whether the research topics were aligned with the p…
Pain, Substance Use Disorders, Mental Health, and Buprenorphine Treatment among Patients With and Without HIV
Open AccessEmily A Miller, Kathleen A McGinnis et al.ARTICLEAIDS and Behavior2024
Treatment of opioid use disorder (OUD) with buprenorphine improves outcomes and mortality among people with HIV (PWH). However, engagement is low and is influenced by comorbidities. We examined the impact of patterns of co-occurring pain, substance use disorders (SUDs), and mental health diagnoses on buprenorphine initiation and retention in PWH. The Veterans Aging Cohort Study contained 7,875 patients (2,702 PWH and 5,173 without HIV) with new O…
Availability of substance use screening and treatment within HIV clinical sites across seven geographic regions within the IeDEA consortium
Open AccessKathryn E Lancaster, Melissa A Stockton et al.ARTICLEInternational Journal of Drug…2024
Availability of screening and treatment for AUD/SUD in HIV care settings is limited, leaving a substantial gap for integration into ongoing HIV care. A critical understanding is needed of the multilevel implementation factors or feasible implementation strategies for integrating screening and treatment of AUD/SUD into HIV care settings, particularly for resource-constrained regions
The Global Task Force for Chronic Pain in People with HIV (PWH)
Jessica S Merlin, Megan Hamm et al.ARTICLEAIDS Care2023
Chronic pain is a common comorbidity in people with HIV (PWH), with prevalence estimates of 25-85%. Research in this area is growing, but significant gaps remain. A Global Task Force of HIV experts was organized to brainstorm a scientific agenda and identify measurement domains critical to advancing research in this field. Experts were identified through literature searches and snowball sampling. Two online questionnaires were developed by Task F…
Prevalence and Correlates of Physical Inactivity Among Individuals with HIV During the First Covid-19 Wave
Open AccessDini Harsono, Yanhong Deng et al.ARTICLEAIDS and Behavior2023
Factors Associated with Bothersome Symptoms in Individuals With and Without HIV Who Report Alcohol Use
Open AccessAnees Bahji, Kirsha S Gordon et al.ARTICLEAIDS and Behavior2023
Substance Use Treatment Engagement among Men Who Have Sex with Men Who Use Stimulants in the Northeastern United States
Adam Viera, Collette Sosnowy et al.ARTICLESubstance Use & Misuse2022
Background Stimulant use is increasing in the United States (U.S.), especially among men who have sex with men (MSM). Objectives: We sought to ascertain barriers and facilitators to substance use treatment utilization among MSM who use stimulants in the northeastern U.S. Methods: We conducted semi-structured interviews with MSM who reported recent stimulant use. Interviews explored perceptions of and experiences with substance use treatment. We u…
Substance Use and Healthcare Utilization Across the Pre-Exposure Prophylaxis (PrEP) Care Cascade among Black and Latino Men Who Have Sex with Men
Ryan J Watson, Ethan Morgan et al.ARTICLESubstance Use & Misuse2022
Background: Despite the documented efficacy of pre-exposure prophylaxis (PrEP) for HIV prevention, large disparities in uptake and adherence exist among Black and Latino/Hispanic men who have sex with men (BLMSM). Limited data exists among BLMSM on the impact of substance use at different stages of the PrEP Care Cascade. We examined the ways substance (alcohol, cannabis, other drug) use is related to PrEP experiences across the PrEP Care Cascade …
Sociodemographic and clinical correlates of gabapentin receipt with and without opioids among a national cohort of patients with HIV
Benjamin J Oldfield, Yu Li et al.ARTICLEAIDS Care2022
Gabapentin is commonly prescribed for chronic pain, including to patients with HIV (PWH). There is growing concern regarding gabapentin's potential for harm, particularly in combination with opioids. Among PWH, we examined factors associated with higher doses of gabapentin receipt and determined if receipt varied by opioid use. We examined data from the Veterans Aging Cohort Study, a national prospective cohort including PWH, from 2002 through 20…
Cannabis use, pain interference, and prescription opioid receipt among persons with HIV
Wesley C Becker, Yu Li et al.ARTICLEAIDS Care2022
Concomitant with expanded legalization, cannabis is increasingly used to treat chronic pain among persons with HIV (PWH), despite equivocal benefit in research limited by small sample sizes and short duration of follow-up. To address these limitations, among a sample of PWH with pain interference enrolled in the Veterans Aging Cohort Study, we performed a target trial emulation study to compare the impact of four cannabis use strategies on pain i…
Self-Reported Cannabis Use and HIV Viral Control among Patients with HIV Engaged in Care
Open AccessAnees Bahji, Yu Li et al.ARTICLEInternational Journal of…2022
Background: The association between cannabis use and HIV-1 RNA (viral load) among people with HIV (PWH) engaged in care is unclear. Methods: We used data collected from 2002 to 2018 on PWH receiving antiretroviral therapy (ART) enrolled in the Veterans Aging Cohort Study. Generalized estimating equations were used to estimate associations between self-reported past-year cannabis use and detectable viral load (≥500 copies/mL), with and without adj…
The Relationship Between Drinking Behavior and Conversational Processes During a Brief Alcohol Reduction Intervention for People with HIV
Open AccessCarolyn Lauckner, Justin Walthers et al.ARTICLEAIDS and Behavior2022
Barriers and Facilitators to HIV Pre-Exposure Prophylaxis Uptake Among Men Who have Sex with Men Who Use Stimulants
Open AccessAdam Viera, Jacob J Van Den Berg et al.ARTICLEAIDS and Behavior2022
Patient-Reported Bothersome Symptoms Attributed to Alcohol Use Among People With and Without HIV
Open AccessKirsha S Gordon, Wesley C Becker et al.ARTICLEAIDS and Behavior2022
Experiences with Telemedicine for HIV Care During the Covid-19 Pandemic
Open AccessDini Harsono, Yanhong Deng et al.ARTICLEAIDS and Behavior2022
Polypharmacy and frailty among persons with HIV
Minhee Sung, Kirsha Gordon et al.ARTICLEAIDS Care2021
Polypharmacy is associated with frailty in the general population, but little is known about polypharmacy among persons living with HIV (PLWH) on antiretroviral (ARV) therapy. We determined the association between polypharmacy and an adapted frailty-related phenotype (aFRP) via a cross-sectional study in FY 2009 of 1762 PLWH on ARV with suppressed viral load and 2679 uninfected participants in the Veterans Aging Cohort Study. The primary predicto…
Twelve-Month Retention in Opioid Agonist Treatment for Opioid Use Disorder Among Patients With and Without HIV
Open AccessJessica J Wyse, Kathleen A McGinnis et al.ARTICLEAIDS and Behavior2021
Long-term Patterns of Self-reported Opioid Use, Vacs Index, and Mortality Among People with HIV Engaged in Care
Open AccessJoella W Adams, Yu Li et al.ARTICLEAIDS and Behavior2021
An Experimental Study of the Effects of Patient Race, Sexual Orientation, and Injection Drug Use on Providers’ PrEP-Related Clinical Judgments
Open AccessSarah K Calabrese, David A Kalwicz et al.ARTICLEAIDS and Behavior2021
Change in Alcohol Use Based on Self-Report and a Quantitative Biomarker, Phosphatidylethanol, in People With HIV
Open AccessKathleen A McGinnis, Janet P Tate et al.ARTICLEAIDS and Behavior2021
Optimizing Provider Preexposure Prophylaxis (PrEP) Training
Open AccessSharanya Rao, Ashley E Reed et al.ARTICLEAIDS and Behavior2021